Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03410823 · ClinicalTrials.gov registry record · NA
PUSH Plus Protein Pilot for Hip Fracture Patients
A NA study, sponsored by University of Maryland, Baltimore.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03410823 is a NA study that was terminated before completion, run by University of Maryland, Baltimore. The registered enrollment target is 20 participants.
The verdict
NCT03410823, a NA study, was terminated before completion, sponsored by University of Maryland, Baltimore.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Hip fracture is a common problem among older individuals. The goal of current standard of care after hip fracture is to achieve independent, household ambulation 2-3 months after surgery, yet decreased functional ability typically persists well beyond three months and many patients never resume independent ambulation outside the home. Previous research has established that one must be able to walk at least 300 meters (\~330 yards) within 6 minutes to re-establish routine interactions in the community, such as going to the store or to church. In part, this is based on the average distance from handicapped parking spaces into most facilities. Activity and exercise are believed to be of benefit for reducing disability in older adults, yet the majority of older adults does not participate in regular exercise and is not active. This is especially true for older adults following hip fracture after they complete the usual rehabilitation program. This research study is being done to test a 16-week, multi-part exercise intervention for hip fracture patients that will be supervised by specially trained physical therapists (PTs). The exercise intervention uses a novel machine to provide strength and endurance training in the home. This has been shown in smaller studies to be safe and effective at increasing strength. The purpose of this small pilot study is to test whether adding a protein supplement to the exercise intervention leads to more improvements in a person's ability to walk in their own home and in the local community. With this knowledge, investigators hope to help a greater number of hip fracture patients enjoy a more complete recovery and improved overall health. In addition to providing important information on adherence, feasibility, and safety, this pilot study of hip fracture patients has the unique advantage of being able to compare data to two recently completed studies where participants received the PUSH intervention without protein supplementation.
Interventions
- DIETARY_SUPPLEMENT Protein
- DIETARY_SUPPLEMENT Nutrition
- BEHAVIORAL PUSH
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-07-16 |
| Est. Completion | 2020-12-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03410823
The ClinicalTrials.gov registry entry for NCT03410823 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Protein is the first listed.
NCT03410823 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03410823 about?
NCT03410823 is a clinical study titled "PUSH Plus Protein Pilot for Hip Fracture Patients". Hip fracture is a common problem among older individuals. The goal of current standard of care after hip fracture is to achieve independent, household ambulation 2-3 months after surgery, yet decreased functional ability typically persists well beyond three months and many patients never resume inde...
What is the current status of trial NCT03410823?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2018-07-16. Estimated completion is 2020-12-12.
What interventions are being tested in trial NCT03410823?
The interventions under investigation include: Protein (DIETARY_SUPPLEMENT), Nutrition (DIETARY_SUPPLEMENT), PUSH (BEHAVIORAL).
Who is sponsoring clinical trial NCT03410823?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.